3 studies found for:    19822896 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Nilotinib
2 Recruiting Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
Conditions: Chronic Myeloid Leukemia in Myeloid Blast Crisis;   Untreated Adult Acute Myeloid Leukemia
Intervention: Drug: Nilotinib+AD induction
3 Active, not recruiting Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase
Condition: Chronic Myeloid Leukemia
Intervention: Drug: Nilotinib

Indicates status has not been verified in more than two years